» Articles » PMID: 31898828

Loss of RAD9B Impairs Early Neural Development and Contributes to the Risk for Human Spina Bifida

Abstract

DNA damage response (DDR) genes orchestrating the network of DNA repair, cell cycle control, are essential for the rapid proliferation of neural progenitor cells. To date, the potential association between specific DDR genes and the risk of human neural tube defects (NTDs) has not been investigated. Using whole-genome sequencing and targeted sequencing, we identified significant enrichment of rare deleterious RAD9B variants in spina bifida cases compared to controls (8/409 vs. 0/298; p = .0241). Among the eight identified variants, the two frameshift mutants and p.Gln146Glu affected RAD9B nuclear localization. The two frameshift mutants also decreased the protein level of RAD9B. p.Ser354Gly, as well as the two frameshifts, affected the cell proliferation rate. Finally, p.Ser354Gly, p.Ser10Gly, p.Ile112Met, p.Gln146Glu, and the two frameshift variants showed a decreased ability for activating JNK phosphorylation. RAD9B knockdowns in human embryonic stem cells profoundly affected early differentiation through impairing PAX6 and OCT4 expression. RAD9B deficiency impeded in vitro formation of neural organoids, a 3D cell culture model for human neural development. Furthermore, the RNA-seq data revealed that loss of RAD9B dysregulates cell adhesion genes during organoid formation. These results represent the first demonstration of a DDR gene as an NTD risk factor in humans.

Citing Articles

Bayesian polygenic risk estimation approach to nuclear families with discordant sib-pairs for myelomeningocele.

Aguayo-Gomez A, Luna-Munoz L, Svyryd Y, Munoz-Tellez L, Mutchinick O PLoS One. 2025; 19(12):e0316378.

PMID: 39774454 PMC: 11684611. DOI: 10.1371/journal.pone.0316378.


Genome-wide analysis of spina bifida risk variants in a case-control study from Bangladesh.

Tindula G, Issac B, Mukherjee S, Ekramullah S, Arman D, Islam J Birth Defects Res. 2024; 116(3):e2331.

PMID: 38526198 PMC: 10963057. DOI: 10.1002/bdr2.2331.


A Shared Pathogenic Mechanism for Valproic Acid and Knockout in a Brain Organoid Model of Neural Tube Defects.

Takla T, Luo J, Sudyk R, Huang J, Walker J, Vora N Cells. 2023; 12(13).

PMID: 37443734 PMC: 10340169. DOI: 10.3390/cells12131697.


A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects.

Takla T, Luo J, Sudyk R, Huang J, Walker J, Vora N bioRxiv. 2023; .

PMID: 37090564 PMC: 10120643. DOI: 10.1101/2023.04.11.536245.


Advantages of CRISPR-Cas9 combined organoid model in the study of congenital nervous system malformations.

Xiaoshuai L, Qiushi W, Rui W Front Bioeng Biotechnol. 2022; 10:932936.

PMID: 36118578 PMC: 9478582. DOI: 10.3389/fbioe.2022.932936.


References
1.
Kibar Z, Bosoi C, Kooistra M, Salem S, Finnell R, De Marco P . Novel mutations in VANGL1 in neural tube defects. Hum Mutat. 2009; 30(7):E706-15. PMC: 2885434. DOI: 10.1002/humu.21026. View

2.
Lei Y, Zhang T, Li H, Wu B, Jin L, Wang H . VANGL2 mutations in human cranial neural-tube defects. N Engl J Med. 2010; 362(23):2232-5. DOI: 10.1056/NEJMc0910820. View

3.
Weiss R, Enoch T, Leder P . Inactivation of mouse Hus1 results in genomic instability and impaired responses to genotoxic stress. Genes Dev. 2000; 14(15):1886-98. PMC: 316817. View

4.
Bray N, Pimentel H, Melsted P, Pachter L . Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016; 34(5):525-7. DOI: 10.1038/nbt.3519. View

5.
Zhang X, Huang C, Chen J, Pankratz M, Xi J, Li J . Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell. 2010; 7(1):90-100. PMC: 2904346. DOI: 10.1016/j.stem.2010.04.017. View